CROCO PRINCESS Cream
Natural health product licensed in Canada
- Other names
- EYUYOU MEIBAI SHUANG
- Licence holder
- Shenzhen Giant Crocodile Biotechnology Corp., Ltd
- NPN or DIN-HM
- 80086723
- Status
- Active licence
- Licence date
- 29 June 2018
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Eau distillée, Palmitate d'éthylhexyle, Parfum, Butylène glycol, (p)-hydroxybenzoate de méthyle, D-Panthénole, Hydroxyéthyl cellulose, Glucoside de cétéaryle, EDTA de sodium, Bisabolol, (p)-hydroxybenzoate de propyle, Sel de magnésium de monophosphate d'ascorbyle, Isononanoate d'isononyle, Alcool cétéarylique, Huile de crocodile, Triglycéride caprylique/caprique/linoléique, Stéarate de PEG-100, Acétate de d-alpha tocophéryle, NA
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | minimum: 1 Crème ; maximum: 2 Crème | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Temporarily protects and helps relieve minor skin irritation and itching.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
No reports known.
- Contre-indications
No reports known.
- Précautions et mises en garde
For external use only (FDA 2003). Avoid contact with eyes (FDA 2003). Consult a healthcare practitioner if symptoms worsen or last for more than 7 days (FDA 2003). Consult a health care practitioner prior to use on children less than 6 months of age.
Source
Official Health Canada record, licence 80086723
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.